The seroprevalence of human herpesvirus 8 infection in the Thai population

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 33, Issue 2, 2002, Pages 297-305

  Ayuthaya, Panasda Isarangkura Na ^a,b   Katano, Harutaka ^c   Inagi, Reiko ^d   Auwanit, Wattana ^b   Sata, Tetsutaro ^c   Kurata, Takeshi ^c   Yamanishi, Koichi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ARTICLE; BLOOD; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOLOGY; ISOLATION AND PURIFICATION; SENSITIVITY AND SPECIFICITY; THAILAND; VIROLOGY;

ANTIBODIES, VIRAL; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; THAILAND;

EID: 0036595812     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ablashi D, Chatlynne L, Cooper H, et al. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Can 1999; 81: 893-7.
2. Cathomas G. Human herpes virus 8: a new virus discloses its face. Virchows Archiv 2000; 436: 195-206.
3. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas. N Engl J Med 1995; 332: 1186-91.
4. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
5. Chatlynne LG, Lappsw W, Handy M, et al. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 1998; 92: 53-8.
6. Davis DA, Humphrey RW, Newcomb FM, et al. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide. J Infect Dis 1997;175: 1071-7.
7. Dupin N, Grandadam M, Calvez V, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995; 345: 761-2.
8. Dupin N, Marcelin AG, Gorin I, et al. Prevalence of human herpesvirus 8 infection measured by antibodies to a latent nuclear antigen in patients with various dermatologic diseases. Arch Dermatol 1998; 134: 700-2.
9. Fujii T, Taguchu H, Katano H, et al. Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan. J Med Virol 1999; 57: 159-62.
10. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996a; 2: 925-8.
11. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996b; 335: 233-41.
12. Huang LM, Huang SY, Chen MY, et al. Geographical differences in Human herpesvirus 8 seroepide-miology: a survey of 1,201 individuals in Asia. J Med Virol 2000; 60: 290-3.
13. Huang YQ, Li JJ, Kaplan MH, et al. Human herpes-virus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995; 345: 759-61.
14. Isarangkura Na Ayuthaya P, Inagi R, Auwanit W, et al. The association of skin diseases with human diseases with human herpesvirus 8 infection in HIV carriers. Arch Virol 1998; 143: 1881-92.
15. Katano H, Iwasaki T, Baba N, et al. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J Virol 2000; 74: 3478-85.
16. Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R. The prevalence of serum antibody to human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative woman. JAMA 1997; 277: 478-81.
17. Klein G, Giovanella B, Westman A, Stehlin JS, Mimford D. An EBV-genome negative cell line established from an American Burkitt lymphoma; Receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 1975; 5: 319-34.
18. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996: 348: 858-61.
19. Li M, MacKey J, Czajak SC, et al. Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein. J Virol 1999; 73: 1341-49.
20. Martin JN, Ganem DE, Osmond DH, et al. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338: 948-54.
21. Mayama S, Cuevas LE, Sheldon J, et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Uganda children and adolescents. Int J Cancer 1998; 77: 817-20.
22. Miller G, Rigsby MO, Heston L, et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-I infection. N Engl J Med 1996; 334:1292-97.
23. Moore P, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995; 332: 1181-85.
24. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpesvirus. Blood 1996; 88: 645-56.
25. Office of the Permanent Secretary for Public Healths, Division of Epidemiology, Ministry of Public Health. Annual Epidemiological Surveillance Report 1996: 64-75.
26. Pau CP, Lam LL, Spira TJ, et al. Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 1998; 36: 1574-7.
27. Rabkin CS, Schulz TF, Whitby D, et al. Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Groups. J Infect Dis 1998; 178: 304-9.
28. Raab MS, Albrecht JC, Birkmann A, et al. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame 8.1 J Virol 1998; 72: 6725-31.
29. Regamey N, Cathomas G, Schwager M, et al. High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland. J Clin Microbiol 1998; 36: 1784-86.
30. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996; 2: 342-46.
31. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348: 1133-38.
32. Soulier J, Grollet L, Okesenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276-80.
33. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346: 799-802.
34. Whitby D, Luppi M, Barozzi P, et al. Human herpesvirus 8 seroprevalence in blood donors and patients with lymphoma from different regions of Italy. J Nat Can Insr 1998; 90. 395-97.